StockData
Covista Inc. logo

Covista Inc. (CVSA) company profile

CVSANYSEServices-Educational ServicesFiscal year ends June 30
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 18/301% below fair value
$116.95−0.79 (-0.67%)

Close on Nov 17, 2026Market cap $3.89BP/E 16.0Yield –

About Covista

Services-Educational Services, SIC 8200

Covista Inc. provides postsecondary healthcare and professional education across five accredited institutions. Its business operates in three reportable segments: Chamberlain, Walden, and Medical and Veterinary. Chamberlain provides onsite and online degree and certificate programs in nursing and health professions. Walden provides online undergraduate and graduate degrees across diverse fields, including nursing, education, counseling, business, behavioral sciences, and public health. The Medical and Veterinary segment encompasses the American University of the Caribbean School of Medicine, Ross University School of Medicine, and Ross University School of Veterinary Medicine, conferring medical and veterinary degrees. The company's primary customers are adult learners, working professionals, and aspiring healthcare practitioners.

The company educates approximately 100,000 students through both digital instruction and physical campuses across several locations. Its network includes 24 Chamberlain campuses across 16 states, medical and veterinary campuses in St. Maarten, Barbados, and St. Kitts, and a medical satellite facility in the United Kingdom. Covista maintains its executive headquarters in Chicago, Illinois.

Summary of the business section of Covista's latest annual report, written by StockData.

Company profile

Company

Legal name
Covista Inc.
Founded
1987
Headquarters
Chicago, IL
Address
233 S. Wacker Drive, Suite 800 60606
Phone
(312) 651-1400
Employees
510, Jun 30, 2007
Industry
Services-Educational Services
Incorporated in
Delaware
Fiscal year ends
June 30
Auditor
PricewaterhouseCoopers LLP, Chicago, Illinois

Stock & identifiers

Ticker
CVSA
Former tickers
ATGE until Feb 24, 2026; AGTE until Jan 25, 2022; DV until Aug 24, 2017
Exchange
NYSE
IPO date
Mar 27, 1997
Shares outstanding
33M, Oct 23, 2026
Public float
$3.49B, Dec 31, 2025
Filer category
Large accelerated filer
Stock splits
2-for-1, Jun 22, 1998; 2-for-1, Dec 19, 1996; 2-for-1, Jun 22, 1995
SEC CIK
730464
CUSIP
00737L103
ISIN
US00737L1035
FIGI
BBG000DQBZJ7
Share class FIGI
BBG001S8M5S3
LEI
549300Z467EZLMODV621
EIN
36-3150143

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Manjunath GangadharanVP, Chief Accounting Officer5,735
Robert J. PhelanChief Financial Officer58,768
Douglas G. BeckSVP, GC, Corp. Sec & ISS34,399
Scott LilesPresident, Medical and Vet15,317
Michael BetzPres. Walden Univ. & SVP-CGIO55,647
Beard, Stephen W.Chairman & CEO459,953
Megan NoelChief Corp. Affairs Officer3,773
Amelia ManningPresident, Chamberlain Univ.6,199
Sara HillCHRO10,258
Karen Sue CoxPresident, Chamberlain Univ.31,596
Evan TrentPresident, Adtalem Elevate24,134
Maurice HerreraSVP - Chief Marketing Officer20,584
Blake SimpsonSVP, Chief Comms & CA Officer8,795
Michael W. MalafronteDirector136,868
Emily C. ChiuDirector1,404
Leslie StormsDirector1,429
Kenneth J. PhelanDirector20,728
William W. BurkeDirector11,316
Sharon O'KeefeDirector17,852
Georgette D. KiserDirector18,345
Donna J. HrinakDirector9,155
Betty M. VandenboschDirector3,449
William V. KrehbielDirector17,168
Lisa W. WardellDirector44,251

CEO pay and shareholder return

Pay versus performance table from the proxy statement

Fiscal yearCEO total payCEO pay actually paidOther executives (avg)Value of $100 investedPeer group
FY2026$19.02M$27.99M$2.48M$350$226
FY2025$17.24M$72.12M$1.97M$357$205
FY2024$14.30M$30.03M$2.39M$191$157
FY2023$8.05M$8.41M$1.70M$96$111
FY2022
Lisa WWardell
$6.28M$6.76M$1.85M$101$105
FY2022
Stephen WBeard
$9.20M$8.97M$1.85M$101$105

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Executive compensation, fiscal 2026

Summary compensation table from the latest proxy statement

ExecutiveSalaryStock awardsIncentive payOtherTotalvs. prior year
Stephen W. Beard
Chairman and Chief Executive Officer
$1.00M$16.00M$1.81M$206.42K$19.02M+10%
Robert J. Phelan
Senior Vice President and Chief Financial Officer
$555.08K$1.38M$514.66K$25.43K$2.47M+23%
Douglas G. Beck
Senior Vice President, General Counsel, Corporate Secretary and Institutional Support Services
$540.97K$669.98K$482.79K$79.13K$1.77M+7%
Michael Betz
Chief Growth & Innovation Officer and President, Walden University
$696.92K$1.80M$958.65K$121.13K$3.58M+38%
Scott Liles
President Medical & Veterinary
$542.35K$843.75K$665.35K$58.68K$2.11M+30%

Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.

Corporate history

Events identified from SEC filings

DateEventDetails
Jan 28, 2026Name changeName changed from Adtalem Global Education Inc. to Covista Inc.
Mar 10, 2022Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Oct 22, 2021Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Aug 12, 2021Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Apr 27, 2020Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Dec 12, 2018Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Dec 6, 2018Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
May 24, 2017Name changeName changed from Adtalem Global Education to Adtalem Global Education Inc.
May 15, 2017Name changeName changed from DEVRY EDUCATION GROUP INC. to Adtalem Global Education
Nov 5, 2013Name changeName changed from DEVRY EDUCATION GROUP to DEVRY EDUCATION GROUP INC.
Nov 25, 2008Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Sep 23, 2008Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Nov 24, 2004ListingRegistration of securities on an exchange (Form 8-A)
Mar 27, 1997IPOInitial public offering priced (424B4 prospectus)
May 8, 1996ListingRegistration of securities on an exchange (Form 8-A)

See a number that looks wrong?